Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)

In Vitro Fungicidal Activities of Echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis Evaluated by Time-Kill Studies

(2010) E. Canton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

(2009) David L. Horn et al.   CLINICAL INFECTIOUS DISEASES

Caspofungin for the treatment of candidaemia in patients with haematological malignancies

(2009) L. Pagano et al.   CLINICAL MICROBIOLOGY AND INFECTION

Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study

(2009) Nikolaos V. Sipsas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The changing epidemiology of invasive candidiasis

(2008) Ray Hachem et al.   CANCER

Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay

(2008) L. J. Wheat et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Successfully treatedCandida kruseiinfection of the lumbar spine with combined caspofungin/posaconazole therapy

(2008) A. Schilling et al.   MEDICAL MYCOLOGY

Candida krusei – a serious complication in patients with hematological malignancies: successful treatment with caspofungin

(2007) A. Conen et al.   Transplant Infectious Disease